Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/13/2013 05/14/2013 05/15/2013 05/16/2013 05/17/2013 Date
15.29(c) 15.41(c) 15.14(c) 15.05(c) 15.01(c) Last
919 092 857 224 533 850 794 408 828 141 Volume
+0.86% +0.78% -1.75% -0.59% -0.27% Change
More quotes
Company
Sector
Pharmaceuticals - Diversified
Calendar
05/21 | 03:00pmPresentation
Surperformance© rating of Auxilium Pharmaceuticals,
Trading Rating : Investor Rating :
More about the company
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 376 M
EBIT 2013 11,3 M
Net income 2013 -2,41 M
Debt 2013 253 M
Yield 2013 -
Sales 2014 463 M
EBIT 2014 45,1 M
Net income 2014 26,6 M
Debt 2014 221 M
Yield 2014 -
PER 2013 -
PER 2014 31,01
EV / Sales 2013 2,64x
EV / Sales 2014 2,08x
Capitalization 740 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
5d ago AUXILIUM PHARMACEUTICALS, INC.: To Present At The UBS Global Health Care Confer..
05/10 AUXILIUM PHARMACEUTICALS, INC.: To Present At The Bank Of America Merrill Lynch..
04/29 AUXILIUM PHARMACEUTICALS, INC.: Auxilium Pharmaceuticals Completes Acquisition ..
04/29 AUXILIUM PHARMACEUTICALS, INC.: Auxilium Pharmaceuticals, Inc, Announces First ..
04/25 AUXILIUM PHARMACEUTICALS, INC.: Auxilium Pharmaceuticals to Announce First Quar..
03/04 AUXILIUM PHARMACEUTICALS, INC.: to Present at the Cowen and Company 33rd Annual..
02/26 AUXILIUM PHARMACEUTICALS, INC.: Announces Fourth Quarter and Full Year 2012 Fin..
02/21AUXILIUM PHARMACEUTICALS, INC.: quaterly earnings release
02/12 AUXILIUM PHARMACEUTICALS, INC.: Auxilium Pharmaceuticals to Announce Fourth Qua..
02/12 AUXILIUM PHARMACEUTICALS, INC.: to Present at the Leerink Swann Global Healthca..
02/01 AUXILIUM PHARMACEUTICALS, INC.: Announces IMPRESS Trials of XIALFEX® in Peyroni..
01/30 AUXILIUM PHARMACEUTICALS, INC.: Announces Issuance of $350.0 Million of 1.50% C..
More news
Forum AUXILIUM PHARMACEUTICALS,
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
EPS Revisions
Auxilium Pharmaceuticals,  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.